Change in ¹⁸F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment

• Shigeru Yamaguchi,

  Affiliations Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, Department of Nuclear-Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Kenji Hirata,

  Affiliation Department of Nuclear-Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Takuya Toyonaga,

  Affiliation Department of Nuclear-Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Kentaro Kobayashi,

  Affiliation Department of Nuclear-Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Yukitomo Ishi,

  Affiliation Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Hiroaki Motegi,

  Affiliation Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Hiroyuki Kobayashi,

  Affiliation Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Tohru Shiga,

  Affiliation Department of Nuclear-Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Nagara Tamaki,

  Affiliation Department of Nuclear-Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Shunsuke Terasaka ,

  * E-mail: terasas@med.hokudai.ac.jp

  Affiliation Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯
• Kiyohiro Houkin

  Affiliation Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

  ⨯